Results 171 to 180 of about 52,582 (257)

Reactive Cutaneous Capillary Endothelial Proliferation in Esophageal Squamous Cell Carcinoma Patients Treated With Camrelizumab‐Based Therapy: A Pooled Analysis of Two Phase 3 Trials

open access: yesMedComm, Volume 7, Issue 8, August 2026.
Camrelizumab‐induced reactive cutaneous capillary endothelial proliferation (RCCEP) was frequent yet manageable in patients with advanced esophageal squamous cell carcinoma and correlated with improved response and survival, suggesting RCCEP as a potential on‐treatment biomarker of clinical benefit.
Jia Liu   +11 more
wiley   +1 more source

Concordance Analysis of Microsatellite Instability via NGS and Mismatch Repair Deficiency via IHC in Endometrial and Colorectal Cancer. [PDF]

open access: yesTarget Oncol
Nero C   +22 more
europepmc   +1 more source

Assimilation of All‐Sky TROPICS Constellation Radiance Data in the NASA Goddard Earth Observing System (GEOS)

open access: yesEarth and Space Science, Volume 13, Issue 8, August 2026.
Abstract This study examines the impact of assimilating all‐sky microwave radiances from the Time‐Resolved Observations of Precipitation structure and storm Intensity with a Constellation of Smallsats (TROPICS) mission within the NASA Global Earth Observing System (GEOS) data assimilation and forecasting framework based on the Gridpoint Statistical ...
Min‐Jeong Kim   +4 more
wiley   +1 more source

Epithelial YPEL3 Modulates CD8+ T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC

open access: yesCancer Science, Volume 117, Issue 8, Page 2132-2151, August 2026.
YPEL3 functions as a tumor suppressor in HNSCC by inhibiting tumor progression and promoting apoptosis. Mechanistically, it enhances epithelial–immune crosstalk through the CREB1‐mediated CXCL16–CXCR6 axis, facilitating CD8+ T‐cell infiltration and highlighting its potential as a prognostic biomarker and immunotherapy target.
Yalun Li   +7 more
wiley   +1 more source

Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer

open access: yesCancer Science, Volume 117, Issue 8, Page 2064-2084, August 2026.
Pyroptosis is a double‐edged sword in colorectal cancer (CRC): chronic low‐grade pyroptosis promotes tumor progression, whereas acute induction of pyroptosis in cancer cells triggers antitumor immunity and enhances therapeutic response. Targeting gasdermin‐mediated pyroptosis represents a promising strategy for CRC treatment.
Kaibo Guo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy